Martha H.  Marsh net worth and biography

Martha Marsh Biography and Net Worth

Martha H. Marsh serves as Lead Independent Director of the Company. Ms. Marsh’s experience of more than 30 years in an increasingly complex and evolving healthcare system as a president and chief executive officer, combined with years of board experience that includes corporate governance chairmanships, provide a unique perspective as our Board considers the execution of our patient-focused innovation strategy.

What is Martha H. Marsh's net worth?

The estimated net worth of Martha H. Marsh is at least $2.56 million as of April 28th, 2022. Ms. Marsh owns 26,777 shares of Edwards Lifesciences stock worth more than $2,558,007 as of March 29th. This net worth approximation does not reflect any other investments that Ms. Marsh may own. Learn More about Martha H. Marsh's net worth.

How do I contact Martha H. Marsh?

The corporate mailing address for Ms. Marsh and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Martha H. Marsh's contact information.

Has Martha H. Marsh been buying or selling shares of Edwards Lifesciences?

Martha H. Marsh has not been actively trading shares of Edwards Lifesciences over the course of the past ninety days. Most recently, Martha H. Marsh sold 28,722 shares of the business's stock in a transaction on Thursday, April 28th. The shares were sold at an average price of $108.09, for a transaction totalling $3,104,560.98. Following the completion of the sale, the director now directly owns 26,777 shares of the company's stock, valued at $2,894,325.93. Learn More on Martha H. Marsh's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, insiders at the medical research company sold shares 59 times. They sold a total of 743,907 shares worth more than $60,273,620.45. The most recent insider tranaction occured on March, 13th when VP Donald E Bobo Jr sold 14,500 shares worth more than $1,319,645.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 3/13/2024.

Martha H. Marsh Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2022Sell28,722$108.09$3,104,560.9826,777View SEC Filing Icon  
See Full Table

Martha H. Marsh Buying and Selling Activity at Edwards Lifesciences

This chart shows Martha H Marsh's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $95.53
Low: $94.87
High: $96.10

50 Day Range

MA: $85.90
Low: $72.55
High: $95.15

2 Week Range

Now: $95.53
Low: $60.57
High: $96.12

Volume

4,007,477 shs

Average Volume

4,077,508 shs

Market Capitalization

$57.44 billion

P/E Ratio

41.53

Dividend Yield

N/A

Beta

1.05